National Institutes for Health Speaking at #BRMEC6 and #IIMEC11

International Research into ME

For TEN years Invest in ME (Research) has been organising international biomedical research conferences in Westminster,London.

For six years we have been organising international research colloquiums which have aimed to initiate new ideas, new research collaborations and exchange of knowledge between ME researchers - and also those from outside the world of ME research.

Invest in ME (Research) celebrates our tenth anniversary as a charity in May 2016.

A special year for the charity - and we are therefore extremely pleased to begin another decade of funding/facilitating biomedical research into ME by announcing that the NIH will be participating in the 6th International Biomedical Research into ME Colloquium on 1-2nd June 2016 - and will be opening the 11th International ME Conference IIMEC11 on 3rd June.
NIH


In our conference news from February we reported that the charity had been in contact with the Director at National Institutes of Health in USA - Dr Francis Collins - inviting him and/or Dr Nath to the #BRMEC6 Colloquium and the #IIMEC11 conference in London in June. As a charity that is funding and facilitating a strategy of high-quality biomedical research into ME we will do all we can to assist in facilitating good and sensible research which will build on our other strategic goal of international collaboration in biomedical research.


So we are very pleased that Dr. Whittemore has accepted our invitation to give keynote speeches at both the BRMEC6 Cooloquium and the IIMEC11 public conference.

Dr. Whittemore is a Program Director in the Synapses, Channels and Neural Circuits Cluster. Her interest is in understanding the underlying mechanisms of the epilepsies including the study of genetic and animal models of the epilepsies. NIH

Dr Whittemore is the NIH representative to the U.S. Department of Health and Human Services’ Chronic Fatigue Syndrome Advisory Committee.

The NIH are considering additional ways to support ME/CFS research in the extramural research community. The basis of the new NIH initiative is "that manifestations of the disorder cut across the science interests of multiple NIH institutes and centers, so a trans-NIH working group will be needed to assist that plan." Along with NINDS Director Walter J. Koroshetz, M.D., Dr Whittemore will chair the Working Group.

One goal of the group will be to explore how new technologies might shed light on what causes ME/CFS.

The Working Group includes representation from 23 NIH institutes, centers and offices.

After our IIMEC2 International ME Conference in 2007 IiME began to develop the strategy of international collaboration in research into ME – which has culminated in the annual International Biomedical Research into ME Colloquiums which the charity arranges and hosts prior to the public international ME conferences.
Having initiated projects relating to microbiome and B-cell research leading to a rituximab trial we have managed to build further collaborations between researchers across Europe and in US and now have regular attendance from the major research teams in Europe, North America and Australia.
The need is for better education, more funding for biomedical research and collaboration between researchers.
This is what Invest in ME (Research) has been dedciated to achieving since 2007.

With most of the experienced researchers present from USA, Europe and Australia, and with additional expertise being brought in from outside the field of ME, then BRMEC6 offers a unique opportunity to move forward - together.

The conferences now attract delegates (researchers, clinicians, media, patient groups, patients, carers, politicians) in a unique event that is friendly and conducive for learning and networking.

Click on the links below for further information